Galena Biopharma Inc (GALE)

0.75
NASDAQ : Health Care
Prev Close 0.75
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.72 / 49.80
Avg Volume 2.21M
Exchange NASDAQ
Shares Outstanding 35.83M
Market Cap 26.87M
EPS -8.20
Div & Yield N.A. (N.A)

Latest News

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Galena Biopharma, Inc.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Galena Biopharma, Inc.

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of Galena Biopharma, Inc.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Galena Biopharma Inc. And Encourages Investors To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Galena Biopharma Inc. And Encourages Investors To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Galena Biopharma Inc.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Galena Biopharma Inc. And Encourages Investors To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Galena Biopharma Inc. And Encourages Investors To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Galena Biopharma Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Galena Biopharma, Inc. - GALE

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Galena Biopharma, Inc. - GALE

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Galena Biopharma, Inc.

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments

Cramer points to Gilead's pipeline for its problems.

How to Expertly Trade Monday's Most Active Stocks -- AMD, Newell Brands, Hasbro and More

How to Expertly Trade Monday's Most Active Stocks -- AMD, Newell Brands, Hasbro and More

Here's how to trade seven of the most active names.

Galena Sacks CEO Amid Escalating Criminal Probe Into Fentanyl Drug Marketing

Galena Sacks CEO Amid Escalating Criminal Probe Into Fentanyl Drug Marketing

The timing of Schwartz' exit is noteworthy given Galena's admission on Jan. 9 of a criminal investigation of the company by the federal prosecutors into the marketing of Abstral.

Post-Trump Rally Stalls as Dow Jones Slips Further From 20,000 Mark

Post-Trump Rally Stalls as Dow Jones Slips Further From 20,000 Mark

The Dow Jones index of blue-chip stocks climbed to within 19 points of the 20,000 milestone before sliding backward, while the Nasdaq dropped from a record opening of 5,499.

Stocks Slump Continues With All S&P 500 Sectors in Negative Territory

Stocks Slump Continues With All S&P 500 Sectors in Negative Territory

The Dow Jones index of blue-chip stocks climbed to within 19 points of the 20,000 milestone on Wednesday before falling backward. The Nasdaq slid from a record opening of 5,499.

Midday Report: Stocks Snatch Earlier Gains as Dow Moves Away From 20,000 Mark

Midday Report: Stocks Snatch Earlier Gains as Dow Moves Away From 20,000 Mark

The Dow Jones index of 30 blue-chip stocks climbed to within 19 points of the milestone on Wednesday before retreating. The Nasdaq slid from a record opening of 5,499.

Stocks Turn Negative, Prolonging Dow's Trek Toward 20,000

Stocks Turn Negative, Prolonging Dow's Trek Toward 20,000

The Dow Jones index of 30 blue-chip stocks climbed to within 19 points of the milestone on Wednesday before retreating. The Nasdaq slid from a record opening of 5,499.

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.